Related Experiment Video
Updated: Apr 16, 2026

09:25
Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
12.1K
Ovarian masses: changing clinico histopathological trends
So Sharadha1, T A Sridevi2, T K Renukadevi2
1Department of Obstetrics and Gynecology, ESIC Medical College and PGIMSR, K.K.Nagar, Chennai, 600078 TamilNadu India.
Journal of Obstetrics and Gynaecology of India
|March 5, 2015
Summary
Ovarian neoplasms are more common than non-neoplastic masses, with a higher incidence in younger women. Serous cystadenoma is the most frequent benign ovarian tumor, while serous cystadenocarcinoma is the most common malignant type.
Area of Science:
- Gynecologic Oncology
- Pathology
- Oncology
Background:
- Ovarian masses represent a significant clinical challenge.
- Understanding their presentation is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To investigate the clinical and histopathological characteristics of ovarian masses.
- To analyze the incidence and types of ovarian neoplasms.
Main Methods:
- Retrospective analysis of 205 ovarian mass cases.
- Data collected from May 2009 to June 2013.
Main Results:
- Ovarian masses occurred in 6.9% of cases, with 68% being neoplastic.
- Benign neoplasms (87.8%) were more common than malignant (10%) or borderline (2.2%).
- Serous cystadenoma (67%) was the most common benign tumor; Serous cystadenocarcinoma (42.9%) was the most common malignant type. Malignant tumors presented at later stages (III/IV) in 71.4% of cases.
Conclusions:
- Ovarian neoplasms are twice as common as non-neoplastic masses.
- The mean age for malignant ovarian tumors has decreased.
- An increasing trend in Mucinous cystadenoma incidence was observed.
Related Concept Videos
Tumor Progression
8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression
3.6K
3.6K
Ovaries
3.6K
The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
On the ovarian surface, a layer of...
3.6K
Oogenesis
71.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
71.7K
Ovarian Cycle
5.7K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.7K

